Cite
HARVARD Citation
Hu, P. et al. (2022). A monoclonal antibody against basic fibroblast growth factor attenuates cisplatin resistance in lung cancer by suppressing the epithelial-mesenchymal transition. International journal of immunopathology and pharmacology. p. . [Online].